Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create targeted, highly active, and less toxic medicines.
Location: United States, Washington, Seattle
Employees: 11-50
Total raised: $93M
Founded date: 2021
Investors 2
Date | Name | Website |
10.11.2023 | 3x5 Partne... | 3x5partner... |
23.01.2023 | Vivo Capit... | vivocapita... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
15.11.2022 | Series A | $93M | Vivo Capit... | - |
Mentions in press and media 2
Date | Title | Description | Source |
15.11.2022 | Seattle biotech startup born out of a Roche buyout lands $93... | Seattle-based Bonum Therapeutics designs therapies that can be administered systemically for targete... | geekwire.c... |
- | Bonum Therapeutics | “Bonum Therapeutics is focused on a proven technology that utilizes allosteric regulation to create ... | fastfounde... |